OmniAb Inc (NASDAQ: OABI) kicked off on Tuesday, down -7.74% from the previous trading day, before settling in for the closing price of $1.68. Over the past 52 weeks, OABI has traded in a range of $1.63-$4.96.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 1.70%. While this was happening, its average annual earnings per share was recorded 2.05%. With a float of $97.79 million, this company’s outstanding shares have now reached $121.60 million.
Let’s determine the extent of company efficiency that accounts for 114 employees. In terms of profitability, gross margin is 16.26%, operating margin of -282.1%, and the pretax margin is -270.59%.
OmniAb Inc (OABI) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of OmniAb Inc is 19.19%, while institutional ownership is 52.30%. The most recent insider transaction that took place on Apr 07 ’25, was worth 38,764. In this transaction President and CEO of this company sold 19,382 shares at a rate of $2.00, taking the stock ownership to the 3,796,236 shares. Before that another transaction happened on Apr 07 ’25, when Company’s Chief Legal Officer sold 7,206 for $2.00, making the entire transaction worth $14,412. This insider now owns 363,212 shares in total.
OmniAb Inc (OABI) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 2.05% per share during the next fiscal year.
OmniAb Inc (NASDAQ: OABI) Trading Performance Indicators
Take a look at OmniAb Inc’s (OABI) current performance indicators. Last quarter, stock had a quick ratio of 4.52. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.49 in one year’s time.
Technical Analysis of OmniAb Inc (OABI)
Looking closely at OmniAb Inc (NASDAQ: OABI), its last 5-days average volume was 1.99 million, which is a jump from its year-to-date volume of 0.78 million. As of the previous 9 days, the stock’s Stochastic %D was 17.48%. Additionally, its Average True Range was 0.13.
During the past 100 days, OmniAb Inc’s (OABI) raw stochastic average was set at 0.38%, which indicates a significant decrease from 2.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.19% in the past 14 days, which was lower than the 66.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.4567, while its 200-day Moving Average is $3.5945. However, in the short run, OmniAb Inc’s stock first resistance to watch stands at $1.6333. Second resistance stands at $1.7167. The third major resistance level sits at $1.7633. If the price goes on to break the first support level at $1.5033, it is likely to go to the next support level at $1.4567. Now, if the price goes above the second support level, the third support stands at $1.3733.
OmniAb Inc (NASDAQ: OABI) Key Stats
The company with the Market Capitalisation of 189.62 million has total of 122,135K Shares Outstanding. Its annual sales at the moment are 26,390 K in contrast with the sum of -62,030 K annual income. Company’s last quarter sales were recorded 10,800 K and last quarter income was -13,070 K.